tiprankstipranks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market

Compare ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.87B
-8.57
3.07%
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
226.49%
2 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$10.74B
30.77
35.93%
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$24.51B
42.36
364.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.34
HK$14.64B
-15.44
314.40%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.15
HK$4.45B
558.59
-13.68%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
5.38
-0.02
-0.37%
HK:1672
Ascletis Pharma, Inc.
17.50
11.73
203.29%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.75
1.58
37.89%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
57.00
44.72
364.17%
HK:2616
CStone Pharmaceuticals
9.90
7.23
270.79%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
7.07
-1.21
-14.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts